Primerica (PRI) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
12 Feb

For the quarter ended December 2024, Primerica (PRI) reported revenue of $790.13 million, up 9.1% over the same period last year. EPS came in at $5.03, compared to $4.25 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $767.24 million, representing a surprise of +2.98%. The company delivered an EPS surprise of +1.41%, with the consensus EPS estimate being $4.96.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Primerica performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Life-Licensed Sales Force, End of period: 151,611 compared to the 152,342 average estimate based on three analysts.
  • Life Insurance Policies Issued: 89,664 versus 91,743 estimated by three analysts on average.
  • Recruits: 95,497 versus the two-analyst average estimate of 93,175.
  • Average Client Asset Values: $112.3 billion versus the two-analyst average estimate of $112.64 billion.
  • Revenues- Commissions and fees: $293.85 million versus $269.24 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +19.1% change.
  • Revenues- Other, net: $17.02 million compared to the $17.22 million average estimate based on five analysts. The reported number represents a change of +0.5% year over year.
  • Revenues- Net premiums: $440.29 million versus $441.28 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +3.8% change.
  • Adjusted Operating Revenues- Investment and Savings Products: $286.05 million compared to the $263.01 million average estimate based on four analysts. The reported number represents a change of +29.1% year over year.
  • Adjusted Operating Revenues- Term Life Insurance: $450.58 million versus $447.61 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +4.5% change.
  • Revenues- Net investment income: $38.13 million compared to the $38.76 million average estimate based on four analysts.
  • Adjusted Operating Revenues- Corporate and Other Distributed Products: $53.51 million versus the three-analyst average estimate of $52.46 million. The reported number represents a year-over-year change of +4.6%.
  • Revenues- Direct premiums: $854.75 million versus $855.99 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.5% change.
View all Key Company Metrics for Primerica here>>>

Shares of Primerica have returned +7% over the past month versus the Zacks S&P 500 composite's +4.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Primerica, Inc. (PRI) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10